On April 1, 2015, researchers from the Baylor College of Medicine, the Chinese University of Hong Kong and the University of Hong Kong have published a study titled Accurate Description of DNA-Based Noninvasive Prenatal Screening in The New England Journal of Medicine. The study found that BGI's NIFTY test performed better than all other NIPT tests examined.
In the study, researchers evaluated the performance of noninvasive prenatal screening in a multicenter cohort of women who had received positive results from the screening and were referred for invasive prenatal diagnostic testing to confirm the presence of fetal aneuploidy. They compared the results of the noninvasive prenatal screening reported by Sequenom, BGI, Illumina, Natera, Ariosa Diagnostics and Integrated Genetics.
Of 307 samples that were reported positive by noninvasive prenatal screening, 238 of the 294 cases (81%) that were later found to have a nonmosaic karyotype were correctly detected. However, 9% of the women who received positive screening results for trisomy 21, 23% for trisomy 18, 46% for trisomy 13, 62% for monosomy X, and 17% for XXX, XXY, or XYY abnormalities were carrying fetuses with normal karyotypes. In addition, another fetus was found to have trisomy 21 and one fetus was found to have monosomy X after routine second-trimester ultrasonography showed fetal abnormalities, although previous results of noninvasive prenatal screening were normal.
Of the 15 false positive cases that were identified at the Chinese University of Hong Kong, 8 (5 with trisomy 21, 1 with trisomy 18, and 2 with trisomy 13) are known to have resulted in the live birth of a newborn with no apparent abnormalities as determined through examination by a pediatrician.
Researchers described that intrinsic biologic factors such as somatic mosaicism, confined placental mosaicism, and maternal copy-number imbalance are true sources of false positive and false negative results of noninvasive prenatal screening. According to the study, BGI's NIFTY Test had a true positive of 87% and false positive of 13%. Among the six laboratories, BGI demonstrated the best test performance.
Through collecting a small sample of peripheral blood from the pregnant woman, NIFTY is able to extract cell free fetal DNA. Utilizing next generation high throughput sequencing technology combined with bioinformatics analysis, NIFTY provides a highly accurate risk rate of occurrence for chromosomal aneuploidy in the fetus. As a non-invasive prenatal test, NIFTY avoids the risk of miscarriage associated with invasive diagnostic procedures such as amniocentesis, which carries a 1% risk of miscarriage.
As of April 2015, NIFTY is offered by more than 2000 healthcare providers in more than 60 countries including England, Australia, Spain, Singapore, Israel, the Czech Republic, Turkey, Thailand and China, with nearly 500,000 test samples processed so far with an accuracy rate of more than 99%.
Considering the intrinsic biologic factors, researchers suggested following the recommendation by the American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine, positive findings on noninvasive prenatal screening must be followed by invasive prenatal diagnostic testing before any irreversible decisions are made.
Explore further: Invasive procedures down with noninvasive prenatal testing
More information: Accurate Description of DNA-Based Noninvasive Prenatal Screening , http://ift.tt/1HbpPDn�
Medical Xpress on facebook
Related Stories
Invasive procedures down with noninvasive prenatal testing
(HealthDay)—The number of invasive diagnostic procedures, including amniocentesis, is down significantly after the introduction of noninvasive prenatal testing (NIPT), according to a study published in ...
Study finds NIPT detects more than 80 percent of chromosomal abnormalities
In a study to be presented on Feb. 6 at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in New Orleans, researchers will report that noninvasive prenatal testing detected 83.2 percent of chromosomal ...
Abnormalities in pregnancies with failures for noninvasive prenatal testing
In a study to be presented on Feb. 6 in an oral concurrent session at 1:15 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in San Diego, researchers will report on the high rate ...
Study confirms accuracy of its NIFTY in nearly 147,000 pregnancies
BGI has published a study tracking the clinical performance of its whole genome sequencing-based non-invasive prenatal test (the NIFTY test) in nearly 147,000 pregnancies, the largest such study to date. The results showed ...
Some false postive prenatal genetic screens due to mother's extra DNA segments
Prenatal blood screening for extra or missing chromosomes in the fetus might give false-positive results if the mother's genome contains more than the usual number of certain DNA segments. This finding is ...
Recommended for you
Is UK evaluation of reproductive tech a model for US?
When the United Kingdom resoundingly approved mitochondrial replacement therapy in February, it became the first country to give people this new medical option. In parallel it gave the United States serious ...
Trio contrast approaches taken by Britain versus the US concerning mitochondrial replacement therapy
(Medical Xpress)—Glenn Cohen, with Harvard University, Julian Savulescu, with the University of Oxford and Eli Adashi with Brown University have together written and published a Perspectives piece in the ...
Candy twists alternative to glucola drink for GDM screening
(HealthDay)—Candy twists can be used as an alternative to glucola beverage in gestational diabetes mellitus screening, according to a study published in the April issue of the American Journal of Obstetrics & ...
Women born early at greater risk of delivering preemies, study suggests
(HealthDay)—Women who were born prematurely may be more likely to deliver their own babies early, a new study suggests.
Study finds IVFpredict one of the most accurate ways of determining chances of IVF success
Accurately predicting the probability of a live birth after in vitro fertilization (IVF) treatment is important for both those undergoing the treatment and their clinicians. Findings from a comparison study ...
Women, regardless of their backgrounds, seek help for the 'got to go' feeling
Regardless of their racial, ethnic, educational or socioeconomic background, women seek help for a frustrating—and ubiquitous—feature of becoming "a woman of a certain age:" the need be close to the women's room.
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here to reset your password.
Sign in to get notified via email when new comments are made.
On April 1, 2015, researchers from the Baylor College of Medicine, the Chinese University of Hong Kong and the University of Hong Kong have published a study titled Accurate Description of DNA-Based Noninvasive Prenatal Screening in The New England Journal of Medicine. The study found that BGI's NIFTY test performed better than all other NIPT tests examined.
In the study, researchers evaluated the performance of noninvasive prenatal screening in a multicenter cohort of women who had received positive results from the screening and were referred for invasive prenatal diagnostic testing to confirm the presence of fetal aneuploidy. They compared the results of the noninvasive prenatal screening reported by Sequenom, BGI, Illumina, Natera, Ariosa Diagnostics and Integrated Genetics.
Of 307 samples that were reported positive by noninvasive prenatal screening, 238 of the 294 cases (81%) that were later found to have a nonmosaic karyotype were correctly detected. However, 9% of the women who received positive screening results for trisomy 21, 23% for trisomy 18, 46% for trisomy 13, 62% for monosomy X, and 17% for XXX, XXY, or XYY abnormalities were carrying fetuses with normal karyotypes. In addition, another fetus was found to have trisomy 21 and one fetus was found to have monosomy X after routine second-trimester ultrasonography showed fetal abnormalities, although previous results of noninvasive prenatal screening were normal.
Of the 15 false positive cases that were identified at the Chinese University of Hong Kong, 8 (5 with trisomy 21, 1 with trisomy 18, and 2 with trisomy 13) are known to have resulted in the live birth of a newborn with no apparent abnormalities as determined through examination by a pediatrician.
Researchers described that intrinsic biologic factors such as somatic mosaicism, confined placental mosaicism, and maternal copy-number imbalance are true sources of false positive and false negative results of noninvasive prenatal screening. According to the study, BGI's NIFTY Test had a true positive of 87% and false positive of 13%. Among the six laboratories, BGI demonstrated the best test performance.
Through collecting a small sample of peripheral blood from the pregnant woman, NIFTY is able to extract cell free fetal DNA. Utilizing next generation high throughput sequencing technology combined with bioinformatics analysis, NIFTY provides a highly accurate risk rate of occurrence for chromosomal aneuploidy in the fetus. As a non-invasive prenatal test, NIFTY avoids the risk of miscarriage associated with invasive diagnostic procedures such as amniocentesis, which carries a 1% risk of miscarriage.
As of April 2015, NIFTY is offered by more than 2000 healthcare providers in more than 60 countries including England, Australia, Spain, Singapore, Israel, the Czech Republic, Turkey, Thailand and China, with nearly 500,000 test samples processed so far with an accuracy rate of more than 99%.
Considering the intrinsic biologic factors, researchers suggested following the recommendation by the American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine, positive findings on noninvasive prenatal screening must be followed by invasive prenatal diagnostic testing before any irreversible decisions are made.
Explore further: Invasive procedures down with noninvasive prenatal testing
More information: Accurate Description of DNA-Based Noninvasive Prenatal Screening , http://ift.tt/1HbpPDn�
Medical Xpress on facebook
Related Stories
Invasive procedures down with noninvasive prenatal testing
(HealthDay)—The number of invasive diagnostic procedures, including amniocentesis, is down significantly after the introduction of noninvasive prenatal testing (NIPT), according to a study published in ...
Study finds NIPT detects more than 80 percent of chromosomal abnormalities
In a study to be presented on Feb. 6 at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in New Orleans, researchers will report that noninvasive prenatal testing detected 83.2 percent of chromosomal ...
Abnormalities in pregnancies with failures for noninvasive prenatal testing
In a study to be presented on Feb. 6 in an oral concurrent session at 1:15 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in San Diego, researchers will report on the high rate ...
Study confirms accuracy of its NIFTY in nearly 147,000 pregnancies
BGI has published a study tracking the clinical performance of its whole genome sequencing-based non-invasive prenatal test (the NIFTY test) in nearly 147,000 pregnancies, the largest such study to date. The results showed ...
Some false postive prenatal genetic screens due to mother's extra DNA segments
Prenatal blood screening for extra or missing chromosomes in the fetus might give false-positive results if the mother's genome contains more than the usual number of certain DNA segments. This finding is ...
Recommended for you
Is UK evaluation of reproductive tech a model for US?
When the United Kingdom resoundingly approved mitochondrial replacement therapy in February, it became the first country to give people this new medical option. In parallel it gave the United States serious ...
Trio contrast approaches taken by Britain versus the US concerning mitochondrial replacement therapy
(Medical Xpress)—Glenn Cohen, with Harvard University, Julian Savulescu, with the University of Oxford and Eli Adashi with Brown University have together written and published a Perspectives piece in the ...
Candy twists alternative to glucola drink for GDM screening
(HealthDay)—Candy twists can be used as an alternative to glucola beverage in gestational diabetes mellitus screening, according to a study published in the April issue of the American Journal of Obstetrics & ...
Women born early at greater risk of delivering preemies, study suggests
(HealthDay)—Women who were born prematurely may be more likely to deliver their own babies early, a new study suggests.
Study finds IVFpredict one of the most accurate ways of determining chances of IVF success
Accurately predicting the probability of a live birth after in vitro fertilization (IVF) treatment is important for both those undergoing the treatment and their clinicians. Findings from a comparison study ...
Women, regardless of their backgrounds, seek help for the 'got to go' feeling
Regardless of their racial, ethnic, educational or socioeconomic background, women seek help for a frustrating—and ubiquitous—feature of becoming "a woman of a certain age:" the need be close to the women's room.
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here
to reset your password.
Sign in to get notified via email when new comments are made.
0 comments:
Post a Comment